New SCI HGE 1500 Encapsulator Produces 90,000 Multiple Dosage Combinations per Hour at Savings Up to 70 Percent
* Reuters is not responsible for the content in this press release.
RIVIERA BEACH, FL, Mar 31 (MARKET WIRE) --
Sancilio & Company, Inc. (http://www.sancilio.com) announces immediate
delivery of the SCI HGE 1500 Encapsulator.
Capable of producing 1,500 capsules per minute (90,000 per hour), the SCI
HGE
1500 Encapsulator is designed for multifunctional, high speed automatic filling
of
hard gelatin capsules with powder, granules, micro tablets or any
combination of these substrates. Typical combinations include 3 different
tablets, 2 granulations and one tablet, granulation and tablet, and various
granulations.
According to Fred D. Sancilio, PhD, CEO and Chief Scientist of Sancilio &
Company, Inc., "The SCI HGE 1500 Encapsulator is one of several models
thatallow pharmaceutical manufacturers to develop very complex combinations of
incompatible active ingredients in a single dosage form. This approach enables
drug designers to offer a wide range of sophisticated release profiles from a
single machine application."
"Meeting all the requirements of GMP," he continued, "The entire line of SCI
HGE Encapsulators is electronically controlled, fully enclosed and is
equipped with a high precision drive system. The SCI HGE 1500 is an ideal
solution for generic, nutritional and vitamin companies who have budget
constraints, yet require a robust, heavy duty capsule filling machine.
Ourprices are significantly lower than traditional equipment manufactured in
the United States and Europe, offering savings as much as 70 percent and
costs far less than even used equipment."
FREE AIR TRAVEL TO SUNNY FLORIDA!
For a limited time, customers can visit the Sancilio factory near sunny
South
Florida beaches to inspect and familiarize themselves with their new machine.
Minimum purchase requirements and certain restrictions apply. This offer is
available to purchasers of new equipment only. Offer expires 06/30/08.
About Sancilio & Company, Inc. (SCI)
SCI was founded in 2006 by Dr. Frederick Sancilio. The focus of SCI is to
provide pharmaceutical and nutritional companies access to high quality
butlow cost alternatives to major providers of machinery, products and services.
Leveraging over 30 years of experience, SCI has established relationships
with all the
major pharmaceutical companies and regulatory agencies to speed up the drug
approval process by providing insightful methods of getting things done in a
cost effective manner. SCI can provide expert advice to get products on the
market cost effectively. We can also provide the machinery needed to expedite
the process in a timely fashion.
SCI maintains corporate and scientific operations at 3874 Fiscal Court,
Suite
200, Riviera Beach, Florida. Additional locations: Pudong District, Shanghai,
PRC
and Montville, N.J., USA.
For further information contact:
Dan Joy
Sancilio & Company
561-847-2302
Email Contact
or
Steven Swartz
SIZZLE PR
978-524-9595
Email Contact
Copyright 2008, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters